University of Southampton
southampton.ac.ukTotal trials
119
Active
23
Phase 3
5
Total enrollment
2,257,446
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 12 of 12 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Flucloxacillin Only Product in Oral Dose Form | — | — | — | — | — | 1 | |
| Mitomycin c | — | — | — | — | — | 1 | |
| Rituximab | — | — | — | — | — | 2 | |
| Ifosfamide | — | — | — | — | — | 2 | |
| Carboplatin | — | — | — | — | — | 2 | |
| Pembrolizumab | — | — | — | — | — | 1 | |
| Etoposide | — | — | — | — | — | 1 | |
| Trastuzumab deruxtecan | — | — | — | — | — | 1 | |
| BMS-986504 | — | — | — | — | — | 1 | |
| PD-1 vaccine IMU-201 | — | — | — | — | — | 1 | |
| Bordetella pertussis B1917 | — | — | — | — | — | 2 | |
| Azithromycin Pill | — | — | — | — | — | 1 |
Next readouts
- 2026-03-31
- 2026-05
- 2026-05-30
- 2026-12-01
- 2027-03-31
- 2027-07
- 2028-09
Top conditions
- Stroke6
- Asthma5
- Parkinson Disease4
- Colorectal Cancer3
- Chronic Obstructive Pulmonary Disease3
- Meningitis, Bacterial3
- Malnutrition3
- Chronic Pain3
Frequently asked questions about University of Southampton
- How many clinical trials does University of Southampton have on ClinicalTrials.gov?
- University of Southampton is listed as the lead sponsor on 119 clinical trials in ClinicalTrials.gov, 23 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Southampton's trials are in Phase 3?
- 5 of University of Southampton's trials are in Phase 3, spread across 12 active drug programs.
- What therapeutic areas does University of Southampton focus on?
- University of Southampton's most-studied conditions on ClinicalTrials.gov are Stroke, Asthma, Parkinson Disease, Colorectal Cancer, Chronic Obstructive Pulmonary Disease.
- When are University of Southampton's next clinical trial readouts?
- University of Southampton has 7 upcoming primary-completion readouts tracked here; the soonest is “Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer”, expected around 2026-03-31.